CONNECT WITH US
Funding Tracker

Funding Tracker

Medical tourism startup CureMeAbroad raises $1.1 million in pre-seed funding led by SteerX Ventures

Indian Startup News – Funding logo

Published on

Add as a preferred source on Google
Medical tourism startup CureMeAbroad raises $1.1 million in pre-seed funding led by SteerX Ventures

Healthtech startup CureMeAbroad has raised $1.1 million in a pre-seed funding round led by healthcare-focused venture capital fund SteerX Ventures, with existing investor AIRA also participating.

The startup said the fresh capital will be used to expand its network of accredited hospitals, enter new patient source markets and strengthen its AI-powered technology. It also plans to build its operations and technology teams.

CureMeAbroad is also looking to expand its treatment offerings into non-elective specialties, including orthopaedics and oncology, and is exploring physical experience centres in key international markets.

The latest funding follows a $600,000 pre-seed round announced in April 2026, which included backing from Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, Vikrant Potnis and AIRA Buildon.

Founded in June 2025 by Aditya Oza and Mikhail Bohra, Pune-headquartered CureMeAbroad helps patients seeking treatment overseas find and compare hospitals and arrange their care.

Its platform allows patients to check healthcare providers against Joint Commission International, or JCI, accreditation or equivalent national standards, obtain treatment estimates and book care. It also provides support during the treatment journey.

CureMeAbroad's platform combines healthcare discovery, treatment planning, pricing transparency and patient assistance.

CureMeAbroad currently attracts more than 22,500 visitors a month and operates a hospital network spanning six countries. In September, Global Healthcare Accreditation, or GHA, awarded CureMeAbroad its Medical Travel Facilitator Certification.

GHA said the company's network includes more than 400 accredited hospital partners across six countries and supports patients from their initial search and comparison of treatment options through to treatment and post-treatment follow-up.


Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.